课题基金 / 基金详情

INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM

INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM
IDDM 中吸入人胰岛素与常规皮下胰岛素治疗的比较
批准号：
6279953
负责人：
ALAN C MOSES
金额：
$2.49万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6279953
关键词：
clinical research clinical trial phase I drug administration routes drug screening /evaluation hormone therapy human subject human therapy evaluation inhalation drug administration injection /infusion insulin insulin dependent diabetes mellitus

项目摘要

项目成果

ALAN C MOSES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This open-label, 3 month, parallel study in subjects with Type I diabetes mellitus will compare the safety and efficacy of an inhaled human insulin therapeutic regimen with that of a conventional human insulin injection regimen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES
CHARACTERIZATION OF INSULIN & INSULIN LIKE GROWTH FACTOR RESPONSES
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM
PILOT STUDY OF A NOVEL, NONINVASIVE METHOD OF BLOOD GLUCOSE MONITORING
海外基金